CareMates vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 40)

CareMates

Emerginghealthcare

AI care facility management

German AI startup digitizing patient admission and care planning for nursing facilities. Won AI+MUNICH grant; reduces admin time by up to 80%.

AI VisibilityBeta
Overall Score
C40
Category Rank
#9 of 9
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
44
Perplexity
36
Gemini
45

About

CareMates is a German AI healthcare startup founded in 2024 that digitizes the patient admission process for nursing and care facilities. Its platform features AI-powered nursing history, automated care planning, document extraction with handwriting recognition, and GDPR-compliant data processing on German servers.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

40
Overall Score
90
#9
Category Rank
#9
77
AI Consensus
60
stable
Trend
stable
44
ChatGPT
99
36
Perplexity
99
45
Gemini
83
42
Claude
96
45
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.